Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young JA, Bennett JE.

Clin Infect Dis. 2016 Aug 15;63(4):e1-e60. doi: 10.1093/cid/ciw326. Epub 2016 Jun 29.

2.

A 10-year study reveals clinical and laboratory evidence for the 'semi-invasive' properties of chronic pulmonary aspergillosis.

Chan JF, Lau SK, Wong SC, To KK, So SY, Leung SS, Chan SM, Pang CM, Xiao C, Hung IF, Cheng VC, Yuen KY, Woo PC.

Emerg Microbes Infect. 2016 Apr 20;5:e37. doi: 10.1038/emi.2016.31.

3.

Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.

Johnson GL, Sarker SJ, Nannini F, Ferrini A, Taylor E, Lass-Flörl C, Mutschlechner W, Bustin SA, Agrawal SG.

J Clin Microbiol. 2015 Jul;53(7):2103-8. doi: 10.1128/JCM.00110-15. Epub 2015 Apr 22.

4.

Micafungin compared with caspofungin for the treatment of febrile episodes in neutropenic patients with hematological malignancies: A retrospective study.

Shalhoub S, Wang L, Ching A, Husain S, Rotstein C.

Can J Infect Dis Med Microbiol. 2014 Nov-Dec;25(6):299-304.

5.

Validation of a new Aspergillus real-time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid.

Chong GL, van de Sande WW, Dingemans GJ, Gaajetaan GR, Vonk AG, Hayette MP, van Tegelen DW, Simons GF, Rijnders BJ.

J Clin Microbiol. 2015 Mar;53(3):868-74. doi: 10.1128/JCM.03216-14. Epub 2015 Jan 7.

6.

Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing.

Nucci M, Carlesse F, Cappellano P, Varon AG, Seber A, Garnica M, Nouér SA, Colombo AL.

PLoS One. 2014 Jan 28;9(1):e87784. doi: 10.1371/journal.pone.0087784. eCollection 2014.

7.

Early diagnosis of invasive pulmonary aspergillosis in hematologic patients: an opportunity to improve the outcome.

Nucci M, Nouér SA, Cappone D, Anaissie E.

Haematologica. 2013 Nov;98(11):1657-60. doi: 10.3324/haematol.2013.094359. No abstract available.

8.

Aspergillus PCR-based investigation of fresh tissue and effusion samples in patients with suspected invasive Aspergillosis enhances diagnostic capabilities.

Reinwald M, Spiess B, Heinz WJ, Heussel CP, Bertz H, Cornely OA, Hahn J, Lehrnbecher T, Kiehl M, Laws HJ, Wolf HH, Schwerdtfeger R, Schultheis B, Burchardt A, Klein M, Dürken M, Claus B, Schlegel F, Hummel M, Hofmann WK, Buchheidt D.

J Clin Microbiol. 2013 Dec;51(12):4178-85. doi: 10.1128/JCM.02387-13. Epub 2013 Oct 9.

9.

Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience.

Neofytos D, Treadway S, Ostrander D, Alonso CD, Dierberg KL, Nussenblatt V, Durand CM, Thompson CB, Marr KA.

Transpl Infect Dis. 2013 Jun;15(3):233-42. doi: 10.1111/tid.12060. Epub 2013 Feb 21.

10.

Comparison of galactomannan enzyme immunoassay performance levels when testing serum and plasma samples.

White PL, Jones T, Whittle K, Watkins J, Barnes RA.

Clin Vaccine Immunol. 2013 Apr;20(4):636-8. doi: 10.1128/CVI.00730-12. Epub 2013 Feb 6.

11.

Have novel serum markers supplanted tissue diagnosis for invasive fungal infections in acute leukemia and transplantation?

Wingard JR.

Best Pract Res Clin Haematol. 2012 Dec;25(4):487-91. doi: 10.1016/j.beha.2012.10.013. Epub 2012 Oct 23. Review.

12.

Epidemiology, outcomes, and risk factors of invasive fungal infections in adult patients with acute myelogenous leukemia after induction chemotherapy.

Neofytos D, Lu K, Hatfield-Seung A, Blackford A, Marr KA, Treadway S, Ostrander D, Nussenblatt V, Karp J.

Diagn Microbiol Infect Dis. 2013 Feb;75(2):144-9. doi: 10.1016/j.diagmicrobio.2012.10.001. Epub 2012 Nov 8.

13.

Use of antifungal drugs in hematology.

Nucci M.

Rev Bras Hematol Hemoter. 2012;34(5):383-91. doi: 10.5581/1516-8484.20120095.

14.

Invasive aspergillosis among heart transplant recipients is rare but causes rapid death due to septic shock and multiple organ dysfunction syndrome.

Shields RK, Nguyen MH, Shullo MA, Silveira FP, Kwak EJ, Abdel Massih RC, Toyoda Y, Bermudez CA, Bhama JK, Kormos RL, Clancy CJ.

Scand J Infect Dis. 2012 Dec;44(12):982-6. doi: 10.3109/00365548.2012.705018. Epub 2012 Jul 25.

15.

A novel extraction method combining plasma with a whole-blood fraction shows excellent sensitivity and reproducibility for patients at high risk for invasive aspergillosis.

Springer J, Schloßnagel H, Heinz W, Doedt T, Soeller R, Einsele H, Loeffler J.

J Clin Microbiol. 2012 Aug;50(8):2585-91. doi: 10.1128/JCM.00523-12. Epub 2012 May 16.

16.

Baseline platelet count and creatinine clearance rate predict the outcome of neutropenia-related invasive aspergillosis.

Nouér SA, Nucci M, Kumar NS, Grazziutti M, Restrepo A, Anaissie E.

Clin Infect Dis. 2012 Jun;54(12):e173-83. doi: 10.1093/cid/cis298. Epub 2012 Mar 15.

17.

Epidemiology of Invasive Fungal Infections in Latin America.

Sifuentes-Osornio J, Corzo-León DE, Ponce-de-León LA.

Curr Fungal Infect Rep. 2012 Mar;6(1):23-34. Epub 2012 Jan 5.

18.

Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity.

D'Haese J, Theunissen K, Vermeulen E, Schoemans H, De Vlieger G, Lammertijn L, Meersseman P, Meersseman W, Lagrou K, Maertens J.

J Clin Microbiol. 2012 Apr;50(4):1258-63. doi: 10.1128/JCM.06423-11. Epub 2012 Feb 1.

19.

Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients.

Bergeron A, Porcher R, Menotti J, Poirot JL, Chagnon K, Vekhoff A, Cornet M, Isnard F, Raffoux E, Brethon B, Lacroix C, Touratier S, Latgé JP, Bouges-Michel C, Tazi A, Derouin F, Ribaud P, Sulahian A.

J Clin Microbiol. 2012 Mar;50(3):823-30. doi: 10.1128/JCM.00750-11. Epub 2011 Dec 14.

20.

Earlier response assessment in invasive aspergillosis based on the kinetics of serum Aspergillus galactomannan: proposal for a new definition.

Nouér SA, Nucci M, Kumar NS, Grazziutti M, Barlogie B, Anaissie E.

Clin Infect Dis. 2011 Oct;53(7):671-6. doi: 10.1093/cid/cir441. Epub 2011 Aug 16.

Supplemental Content

Support Center